Cardipril (ramipril) capsules 5 mg. №30

Description

Treatment of hypertension.
Prevention of cardiovascular disease: reduction of cardiovascular morbidity and mortality in patients with:
pronounced cardiovascular disease of atherothrombotic origin (the presence of a history of coronary heart disease or stroke or peripheral vascular disease);
diabetes mellitus that have at least one cardiovascular risk factor.
Treatment of kidney disease:
initial glomerular diabetic nephropathy, evidenced by the presence of microalbuminuria;
pronounced glomerular diabetic nephropathy, evidenced by the presence of macroproteinuria, in patients who have at least one cardiovascular risk factor;
expressed glomerular nondiabetic nephropathy, which is evidenced by the presence of macroproteinuria ≥ 3 g per day.
Treatment of heart failure, which is accompanied by clinical manifestations.
Secondary prophylaxis after acute myocardial infarction: reduction of mortality during the acute stage of myocardial infarction in patients with clinical signs of heart failure if treatment is started more than 48 hours after the occurrence of acute myocardial infarction.